Summary
ABT Chart
Best Dividend Kings: June 2025
Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a collective 2025 growth rate of 5.19%, despite some downward earnings revisions. Seventeen Dividend Kings appear undervalued and offer long-term annualized expected returns of at least 10%, based on Dividend Yield Theory analysis.
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and fruit, and reported significantly improved health status. Abbott's Healthy Food Rx community-focused "food is medicine" program provides home-delivered healthy food boxes and nutrition education in Stockton, Calif.
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Abitare In S.p.A. Dividends
 ABT In 2 weeks Announced | Quarterly | $0.59 Per Share |
| ABT 2 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 5 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 8 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
Abitare In S.p.A. Earnings
| 16 Jul 2025 (In 3 weeks) Date | | 1.25 Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| 18 Jul 2024 Date | | 1.1 Cons. EPS | 1.14 EPS |
| ABT In 2 weeks Announced | Quarterly | $0.59 Per Share |
| ABT 2 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 5 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 8 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
| 16 Jul 2025 (In 3 weeks) Date | | 1.25 Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| 18 Jul 2024 Date | | 1.1 Cons. EPS | 1.14 EPS |
Abitare In S.p.A. (ABT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Abitare In S.p.A. ever had a stock split?
Abitare In S.p.A. Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | XMIL Exchange | US0028241000 ISIN |
| US Country | 114,000 Employees | 15 Jul 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
